Chairman's Annual Report 2016

Read Now >
Medication Slows Devastating Lung Disease

Medication Slows Devastating Lung Disease

Read more

Genetic Link to Sudden Cardiac Death Revealed

Read more

Latest News

Family medicine residents Alicia Kepich, M.D. and Ingrid Gutierrez, M.D., role play with Kassandra M. Bosire, M.D.

Program Teaches Residents and Fellows to Redirect ‘Difficult’ Patient Encounters

A new teaching model developed at the University of Miami Miller School of Medicine educates residents and fellows on how to effectively redirect patients during difficult interactions. Called “The 7Cs protocol,” it provides a framework for junior physicians to act, versus react, during stressful patient encounters.

Read more »

Margaret Fischl, M.D., and UM clinical research nurses demonstrate how the needle-free injector will be used to administer an experimental Zika vaccine in a Phase 2 trial led by the National Institutes of Health.

University of Miami to Begin Phase 2 Zika Vaccine Trial

The University of Miami Miller School of Medicine will soon begin one of the nation’s first full-scale Zika vaccine clinical trials testing the National Institutes of Health’s (NIH) experimental DNA-based vaccine. As Miami-Dade County has been ground zero for the Zika virus outbreak in the U.S., testing the vaccine in an endemic region is critical to help determine the vaccine’s safety.

Read more »

Lilian Abbo, M.D.

Lilian Abbo Speaks at Infectious Disease Conference in London

Lilian Abbo, M.D., associate professor of clinical infectious diseases at the Miller School of Medicine and Chief of Infection Prevention and Antimicrobial Stewardship for Jackson Health System, was an invited speaker at the prestigious British Society of Antimicrobial Chemotherapy Spring Conference in London. The subject was “The Global Challenge of Multi-drug Resistant Gram Negative Bacterial Infections.”

Read more »

More News »